secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K
Filed at:   2025-02-18T23:59:59+00:00
Accession:  0001213900-25-014928
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 2.03, 4.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix issues $117k promissory note, changes auditor, strategy officer resigns
--------------------------------------------------------------------------------

- Entered $117,647 promissory note with Keystone Capital; purchase price $100k, due Nov 12, 2025 or earlier from ELOC proceeds.
- Appointed MaloneBailey LLP as new independent auditor effective Feb 13, 2025; no prior disagreements or reportable events.
- Christian Brühlmann resigned as Chief Strategy Officer on Feb 18, 2025; remains as Chief Business Officer of Proteomedix AG.
- Note is subordinate to existing Veru Inc debt obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390025014928/0001213900-25-014928-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390025014928/ea0231345-8k_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-014928

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer